ArticleBMC cancer2023

Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study.

Xiao-Xu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.